T. Rowe Price Investment Management
BNTX icon

T. Rowe Price Investment Management’s BioNTech BNTX Stock Holding History

T. Rowe Price Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$520M Buy
5,856,073
+1,371,474
+31% +$141M 0.36% 74
2025
Q4 		$427M Sell
4,484,599
-349,043
-7% -$35.2M 0.27% 93
2025
Q3 		$477M Buy
4,833,642
+1,235,170
+34% +$132M 0.29% 90
2025
Q2 		$383M Buy
3,598,472
+3,512,318
+4,077% +$355M 0.24% 114
2025
Q1 		$7.85M Buy
86,154
+32,818
+62% +$3.67M 0.01% 570
2024
Q4 		$6.08M Buy
+53,336
New +$6.09M ﹤0.01% 569

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $152B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GP
GSK plc London $599M AUM